These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2283244)

  • 1. Adverse reactions to intravenous contrast media in routine clinical practice.
    Wolf GL; Silvay-Mandeau O
    Invest Radiol; 1990 Sep; 25 Suppl 1():S20-1. PubMed ID: 2283244
    [No Abstract]   [Full Text] [Related]  

  • 2. A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography.
    Munechika H; Hiramatsu Y; Kudo S; Sugimura K; Hamada C; Yamaguchi K; Katayama H
    Eur Radiol; 2003 Jan; 13(1):185-94. PubMed ID: 12541129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed adverse reactions to nonionic contrast medium (iohexol) in IV use: multicentric study.
    Munechika H; Hiramatsu Y; Kudo S; Sugimura K; Hamada C; Yamaguchi K; Katayama H
    Acad Radiol; 2002 May; 9 Suppl 1():S69-71. PubMed ID: 12019899
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute and late adverse reactions to low-osmolal contrast media.
    Mikkonen R; Kontkanen T; Kivisaari L
    Acta Radiol; 1995 Jan; 36(1):72-6. PubMed ID: 7833173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the side-effects of low-osmolar contrast media in intravenous urography.
    Foord KD; Kaye B; Howard J; Cumberland DC
    Clin Radiol; 1985 Jul; 36(4):379-80. PubMed ID: 4064528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective study of adverse reactions to contrast media administered intravenously--a comparison of low-osmolality and high-osmolality contrast media].
    Higashi S; Takizawa K; Suzuki S; Nagashima J; Tamura S; Ishikawa M; Obuchi M; Katayama M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Nov; 48(11):1364-70. PubMed ID: 3237463
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography.
    Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R
    Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156
    [No Abstract]   [Full Text] [Related]  

  • 8. Late and acute adverse reactions to iohexol in a pediatric population.
    Mikkonen R; Kontkanen T; Kivisaari L
    Pediatr Radiol; 1995; 25(5):350-2. PubMed ID: 7567261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-cardiogenic pulmonary oedema after intravenous administration of non-ionic contrast media.
    Hauggaard A
    Acta Radiol; 1996 Sep; 37(5):823-5. PubMed ID: 8915300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients.
    Wendt-Nordahl G; Rotert H; Trojan L; Michel MS; Peters CR; Alken P; Knoll T
    Med Princ Pract; 2006; 15(5):358-61. PubMed ID: 16888393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to intravenous contrast agents in Ontario, 1975 - 1979.
    Hobbs BB
    J Can Assoc Radiol; 1981 Mar; 32(1):8-10. PubMed ID: 7217176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of roentgen contrast medium reactions after intravenous injection in pre-registration trials and post-marketing surveillances.
    Andrew E; Haider T
    Acta Radiol; 1993 May; 34(3):210-3. PubMed ID: 8489831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Late adverse reactions of non-ionic intravenous contrast media].
    Nambu T; Yoshikawa H; Shirato H; Suzuki K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Aug; 50(8):1019-21. PubMed ID: 2235336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ioxilan. Initial clinical observations.
    Callantine MR; Sovak M; Lu HP
    Invest Radiol; 1990 Sep; 25 Suppl 1():S107-8. PubMed ID: 2283219
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonionic iodinated contrast media reactions.
    Lasser EC
    AJR Am J Roentgenol; 2009 Feb; 192(2):W80; author reply W81. PubMed ID: 19155387
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxic epidermal necrolysis after repeated injections of iohexol.
    Rosado A; Canto G; Veleiro B; Rodríguez J
    AJR Am J Roentgenol; 2001 Jan; 176(1):262-3. PubMed ID: 11133587
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of intravenous contrast agents for CT studies in children.
    Cohen MD; Herman E; Herron D; White SJ; Smith JA
    Acta Radiol; 1992 Nov; 33(6):592-5. PubMed ID: 1449887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden hearing loss following drip intravenous pyelography with iohexol: a case report.
    Karino S; Fukaya T
    Auris Nasus Larynx; 2001 Jan; 28(1):95-7. PubMed ID: 11137369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical tolerance and diagnostic efficacy of iobitridol in contrast-enhanced CT in children.
    Smets A; Shaw D
    Acta Radiol Suppl; 1996; 400():65-7. PubMed ID: 8619355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.